Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

The ideal Stars leader of tomorrow needs a specific skill set to produce consistently high Stars rating results for an organization.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness, Health and Life Sciences, Oliver Wyman
Former President of Government Business, Anthem/BCBSM, Senior Adviser, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

An executive interview with Bruce Broussard on Humana's strategic pillars, partnership decisions, and ongoing resiliency.

President and CEO, Humana

Oliver Wyman's research findings on diversity in healthcare leadership (some of which surprised us).

Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Director, Strategy & Corporate Development, Landmark Health
Principal, Oliver Wyman
Consultant

Diversity as a Strategic Priority

How can your I&D goals thrive? Walk the talk, says Florida Blue's CEO.

President and CEO, Florida Blue
Former CEO, Health Evolution
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

A closer look at why only 30 percent of C-suite teams and 13 percent of CEOs are women.

Insights in your inbox

Subscribe

What missed opportunities will incumbents one day wish they had taken advantage of? Adopting a new mentality will disrupt the industry from the inside out.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

How a Chicago hub for healthcare innovation is evolving amidst an industry of fierce technological disruption.

CEO, MATTER

Imagine Health’s CEO, Chris Cigarran, explains how to spark innovation and breathe much needed life to the healthcare industry by focusing where others aren’t.

CEO, Imagine Health

What some of healthcare’s most influential voices had to say about the past, present, and future of the industry on the Summit's final day.

Insights from the Summit’s Executive Sessions where speakers dove deep into topics like consumerism, pharma, the future of trading flow, and artificial intelligence.

Insights in your inbox

Subscribe